Jane H Christensen Selected Research

Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)

1/2018	The Novel Ser18del AVP Variant Causes Inherited Neurohypophyseal Diabetes Insipidus by Mechanisms Shared with Other Signal Peptide Variants.
1/2018	A Novel Synonymous Variant in the AVP Gene Associated with Autosomal Dominant Familial Neurohypophyseal Diabetes Insipidus Causes Partial RNA Missplicing.
1/2017	Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene.
6/2013	A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred.
8/2005	Expression of three different mutations in the arginine vasopressin gene suggests genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds.
9/2004	Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus.
1/2004	Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus.
1/2004	Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis.
1/2003	Autosomal dominant familial neurohypophyseal diabetes insipidus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jane H Christensen Research Topics

Disease

9	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2018 - 01/2003
5	Schizophrenia (Dementia Praecox) 01/2020 - 04/2012
2	Mental Disorders (Mental Disorder) 01/2021 - 01/2016
2	Nephrogenic Diabetes Insipidus 12/2015 - 12/2009
1	Nocturnal Enuresis (Bedwetting) 01/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2018
1	Insulin Resistance 11/2013
1	Obesity 11/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2013
1	Dehydration (Water Stress) 06/2013
1	Hyponatremia 11/2012
1	Failure to Thrive 11/2012
1	Seizures (Absence Seizure) 05/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2012
1	Depressive Disorder (Melancholia) 05/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2006

Drug/Important Bio-Agent (IBA)

8	Arginine Vasopressin (Argipressin)IBA 01/2021 - 01/2003
3	Messenger RNA (mRNA)IBA 01/2019 - 05/2012
2	Pharmaceutical PreparationsIBA 01/2021 - 05/2012
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2021 - 06/2013
2	ChromatinIBA 01/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2006
1	Biological ProductsIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Protein Sorting Signals (Signal Peptide)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Aquaporins (Water Channels)IBA 12/2015
1	Aquaporin 2IBA 12/2015
1	Insulin (Novolin)FDA Link 11/2013
1	AntioxidantsIBA 11/2013
1	LeptinIBA 11/2013
1	SodiumIBA 11/2012
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 11/2012
1	AldosteroneIBA 11/2012
1	SaltsIBA 11/2012
1	Histones (Histone)IBA 05/2012
1	melanin-concentrating hormone receptorIBA 04/2012
1	Vasopressins (Vasopressin)IBA 12/2009
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 12/2009